Prebiotic Properties of Non-Fructosylated α-Galactooligosaccharides from PEA (Pisum sativum L.) Using Infant Fecal Slurries

Foods
María Del Carmen Marín-ManzanoAlfonso Clemente

Abstract

The interest for naturally-occurring oligosaccharides from plant origin having prebiotic properties is growing, with special focus being paid to supplemented products for infants. Currently, non-fructosylated α-galactooligosaccharides (α-GOS) from peas have peaked interest as a result of their prebiotic activity in adults and their mitigated side-effects on gas production from colonic bacterial fermentation. In this study, commercially available non-fructosylated α-GOS from peas and β-galactooligosaccharides (β-GOS) derived from lactose were fermented using fecal slurries from children aged 11 to 24 months old during 6 and 24 h. The modulatory effect of both GOS on different bacterial groups and bifidobacteria species was assessed; non-fructosylated α-GOS consumption was monitored throughout the fermentation process and the amounts of lactic acid and short-chain fatty acids (SCFA) generated were analyzed. Non-fructosylated α-GOS, composed mainly of manninotriose and verbascotetraose and small amounts of melibiose, were fully metabolized and presented remarkable bifidogenic activity, similar to that obtained with β-GOS. Furthermore, non-fructosylated α-GOS selectively caused an increase on the population of Bifidobacterium longu...Continue Reading

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jul 17, 2007·International Journal of Food Microbiology·Marco VenturaDouwe van Sinderen
Apr 17, 2010·Journal of Agricultural and Food Chemistry·Angela MarcobalDavid A Mills
Dec 15, 2010·Journal of Pediatric Gastroenterology and Nutrition·Christian BraeggerUNKNOWN ESPGHAN Committee on Nutrition
Apr 13, 2011·Genes & Nutrition·Karina PokusaevaDouwe van Sinderen
Dec 1, 2011·FEMS Microbiology Ecology·Silvia ArboleyaMiguel Gueimonde
May 19, 2012·PloS One·Francesca TurroniMarco Ventura
Sep 5, 2012·Nature Reviews. Gastroenterology & Hepatology·Harry J FlintSylvia H Duncan
Feb 26, 2013·Current Opinion in Biotechnology·Daniela Barile, Robert A Rastall
Jun 12, 2013·Nature Reviews. Microbiology·Abdessamad El KaoutariBernard Henrissat
Jul 31, 2013·Applied and Environmental Microbiology·Santiago Ruiz-MoyanoDavid A Mills
Mar 4, 2014·Applied and Environmental Microbiology·Anders BergströmTine Rask Licht
Apr 1, 2015·Nature Reviews. Gastroenterology & Hepatology·Laure B BindelsJens Walter
Aug 12, 2015·Nature Reviews. Endocrinology·Emanuel E CanforaEllen E Blaak
Oct 4, 2015·Current Opinion in Biotechnology·Robert W HutkinsMary Ellen Sanders
May 4, 2017·Journal of Agricultural and Food Chemistry·Taksawan ThongaramMichael J Miller
Oct 13, 2018·International Journal of Molecular Sciences·Sophie FehlbaumDaniel Raederstorff
Jan 24, 2019·Pediatric Gastroenterology, Hepatology & Nutrition·Hanifah OswariBadriul Hegar
Mar 13, 2019·Frontiers in Microbiology·Stella VerkhnyatskayaMarthe T C Walvoort
Jun 20, 2019·Frontiers in Nutrition·Gonçalo N MartinsAndrea Gomez-Zavaglia

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
PCR
Electrophoresis

Software Mentioned

BLAST
Agilent ChemStation
Quantity One
SPSS Statistics
AlphaGOS

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.